Oncology Pipelines – Searching is not Finding
Exane BNP Paribas Equity Research Report
Frédéric Desdouits and Stéphane Parnis, in collaboration with Exane BNP Paribas, have produced an in-depth study of the oncology sector, reviewing the past and forecasting future trends.
March, 2006
Therapeutic Peptides Under the Spotlight
Catherine Pichereau and Claude Allary explore the challenges, trends and opportunities within a sector receiving increasing attention.
January, 2006
The European Giant Stirs from Slumber
Biotechnologies et Finances
Frédéric Desdouits and Catherine Pichereau review the evolution of the financial landscape of the Biotech industry in 2005.
December, 2005
Great Oaks from Little Acorns
Scrip Magazine
Alain Gilbert, Mark Larkin, Vanessa Coudre and Xavier Paoli explain how big things can come from small beginnings with an EAP (Early Access Programme).
November, 2005
Pharmacogenomics and personalized medicine: mapping of future value creation
Sean X. Hu, Thomas Foster and Ann Kieffaber.
October, 2005
The Unlikely European Biotech Poker Game
Catherine Pichereau looks at the difficulties European biotech companies encounter raising public funds.
Summer, 2005
Vioxx: Lifting the Veil on the Dark Side of the Pharmaceutical Industry
Catherine Pichereau examines the consequences of the Vioxx scandal.
Spring, 2005
Entry in Europe – Companies from Overseas Face Critical Issues
Biotechnology in Europe Today
Mark Larkin explores the issues faced by companies considering becoming players in the European market.
Autumn, 2004
Risky Business
Scrip Magazine
Alain Gilbert and Mark Larkin discuss how European Biotech companies can be sustainable in a risk-averse environment.
September, 2004
EU biotech: United we Stand, Divided we Fall
Scrip Magazine
Claude Allary and Catherine Pichereau look at the results of a survey examining why there are so few biotech consolidations in Europe, and suggest ways to increase their number.
July/August, 2004
1 3 4 5 6